Delivery Order SPE2DB24D9144-SPE2DB24FCMKH

Award Date 8/22/24
Potential Completion Date 9/13/24
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,145.70 contract is for the supply of EXPAREL 133 MG/10 ML VIAL 10ML, a pharmaceutical product, to support the recurring medical supply needs of military health facilities. This delivery order is placed under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,855.66 contract is for the delivery of EXPAREL 133 MG/10 ML VIAL 10ML pharmaceutical products. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue firm fixed-price delivery...
This is a firm fixed-price delivery order award by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $30,127.56 contract is for the supply of EXPAREL 266 MG/20 ML VIAL 20ML, a specialized pharmaceutical product, to support the medical supply needs of the Department of Defense (DoD). DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $4,039.26, is for the delivery of EXPAREL 133 MG/10 ML VIAL 10ML to support the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $13,172.94 contract is for the delivery of EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product, to support the recurring medical supply needs of military health facilities. This delivery order is part of DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $14,923.32 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, which covers a wide range of pharmaceutical items to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $2,855.64 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of EXPAREL 133 MG/10 ML VIAL 10ML, a pharmaceutical product. This delivery order contract is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $2,855.66 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of EXPAREL 133 MG/10 ML VIAL 10ML to support the medical needs of military health facilities. This Delivery Order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999, which allows the DLA to issue orders...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $14,928.66 award is for the supply of EXPAREL 266 MG/20 ML VIAL 20ML, with a completion date of March 31, 2023. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue delivery orders for...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $4,283.46 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of EXPAREL 133 MG/10 ML VIAL 10ML, with a period of performance through August 6, 2024. This delivery order is part of DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
  • SPE2DB24D9144
    Indefinite Delivery Contract
  • SPE2DB24D9144-SPE2DB24FCMKH
    Delivery Order

This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,427.82 contract is for the supply of EXPAREL 133 MG/10 ML VIAL 10ML, a branded pharmaceutical product, to support the recurring medical supply needs of the U.S. Department of Defense (DoD) healthcare facilities.

DMS Pharmaceutical Group holds a larger, single-award indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which enables the DLA to issue firm fixed-price delivery orders for a wide range of pharmaceutical items to fulfill the diverse medical requirements of the DoD. This latest award is issued under that overarching IDC vehicle, further solidifying DMS Pharmaceutical Group's position as a critical supplier in the federal pharmaceutical supply chain.

Generated 11/21/24, 9:24 AM